» Articles » PMID: 26286186

Viscosity Analysis of Dual Variable Domain Immunoglobulin Protein Solutions: Role of Size, Electroviscous Effect and Protein-Protein Interactions

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 2015 Aug 20
PMID 26286186
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Increased solution viscosity results in difficulties in manufacturing and delivery of therapeutic protein formulations, increasing both the time and production costs, and leading to patient inconvenience. The solution viscosity is affected by the molecular properties of both the solute and the solvent. The purpose of this work was to investigate the effect of size, charge and protein-protein interactions on the viscosity of Dual Variable Domain Immunoglobulin (DVD-Ig(TM)) protein solutions.

Methods: The effect of size of the protein molecule on solution viscosity was investigated by measuring intrinsic viscosity and excluded volume calculations for monoclonal antibody (mAb) and DVD-Ig(TM) protein solutions. The role of the electrostatic charge resulting in electroviscous effects for DVD-Ig(TM) protein was assessed by measuring zeta potential. Light scattering measurements were performed to detect protein-protein interactions affecting solution viscosity.

Results: DVD-Ig(TM) protein exhibited significantly higher viscosity compared to mAb. Intrinsic viscosity and excluded volume calculations indicated that the size of the molecule affects viscosity significantly at higher concentrations, while the effect was minimal at intermediate concentrations. Electroviscous contribution to the viscosity of DVD-Ig(TM) protein varied depending on the presence or absence of ions in the solution. In buffered solutions, negative k D and B 2 values indicated the presence of attractive interactions which resulted in high viscosity for DVD-Ig(TM) protein at certain pH and ionic strength conditions.

Conclusions: Results show that more than one factor contributes to the increased viscosity of DVD-Ig(TM) protein and interplay of these factors modulates the overall viscosity behavior of the solution, especially at higher concentrations.

Citing Articles

Developability considerations for bispecific and multispecific antibodies.

Amash A, Volkers G, Farber P, Griffin D, Davison K, Goodman A MAbs. 2024; 16(1):2394229.

PMID: 39189686 PMC: 11352713. DOI: 10.1080/19420862.2024.2394229.


A bioengineered anti-VEGF protein with high affinity and high concentration for intravitreal treatment of wet age-related macular degeneration.

Huang C, Wang Y, Huang J, Liu H, Chen Z, Jiang Y Bioeng Transl Med. 2024; 9(2):e10632.

PMID: 38435828 PMC: 10905556. DOI: 10.1002/btm2.10632.


Development and biophysical characterization of a humanized FSH-blocking monoclonal antibody therapeutic formulated at an ultra-high concentration.

Rojekar S, Pallapati A, Gimenez-Roig J, Korkmaz F, Sultana F, Sant D Elife. 2023; 12.

PMID: 37334968 PMC: 10325703. DOI: 10.7554/eLife.88898.


Development and Biophysical Characterization of a Humanized FSH-Blocking Monoclonal Antibody Therapeutic Formulated at an Ultra-High Concentration.

Rojekar S, Pallapati A, Gimenez-Roig J, Korkmaz F, Sultana F, Sant D bioRxiv. 2023; .

PMID: 37214886 PMC: 10197643. DOI: 10.1101/2023.05.11.540323.


Determination of Conformational and Functional Stability of Potential Plague Vaccine Candidate in Formulation.

Athirathinam K, Nandakumar S, Verma S, Kandasamy R Vaccines (Basel). 2023; 11(1).

PMID: 36679872 PMC: 9865242. DOI: 10.3390/vaccines11010027.


References
1.
E Zarraga I, Taing R, Zarzar J, Luoma J, Hsiung J, Patel A . High shear rheology and anisotropy in concentrated solutions of monoclonal antibodies. J Pharm Sci. 2013; 102(8):2538-49. DOI: 10.1002/jps.23647. View

2.
Saito S, Hasegawa J, Kobayashi N, Kishi N, Uchiyama S, Fukui K . Behavior of monoclonal antibodies: relation between the second virial coefficient (B (2)) at low concentrations and aggregation propensity and viscosity at high concentrations. Pharm Res. 2011; 29(2):397-410. DOI: 10.1007/s11095-011-0563-x. View

3.
Harding S, Johnson P . The concentration-dependence of macromolecular parameters. Biochem J. 1985; 231(3):543-7. PMC: 1152785. DOI: 10.1042/bj2310543. View

4.
Burckbuchler V, Mekhloufi G, Giteau A, Grossiord J, Huille S, Agnely F . Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutions. Eur J Pharm Biopharm. 2010; 76(3):351-6. DOI: 10.1016/j.ejpb.2010.08.002. View

5.
He F, Woods C, Trilisky E, Bower K, Litowski J, Kerwin B . Screening of monoclonal antibody formulations based on high-throughput thermostability and viscosity measurements: design of experiment and statistical analysis. J Pharm Sci. 2013; 100(4):1330-40. DOI: 10.1002/jps.22384. View